378 related articles for article (PubMed ID: 35893126)
1. Novel Treatment Approach for Aspergilloses by Targeting Germination.
Verburg K; van Neer J; Duca M; de Cock H
J Fungi (Basel); 2022 Jul; 8(8):. PubMed ID: 35893126
[TBL] [Abstract][Full Text] [Related]
2. The C
Baltussen TJH; van Rhijn N; Coolen JPM; Dijksterhuis J; Verweij PE; Bromley MJ; Melchers WJG
mSphere; 2023 Aug; 8(4):e0007623. PubMed ID: 37260230
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Conidial Germination in
Baltussen TJH; Zoll J; Verweij PE; Melchers WJG
Microbiol Mol Biol Rev; 2020 Feb; 84(1):. PubMed ID: 31801804
[TBL] [Abstract][Full Text] [Related]
4. Comparative transcriptome analysis revealing dormant conidia and germination associated genes in Aspergillus species: an essential role for AtfA in conidial dormancy.
Hagiwara D; Takahashi H; Kusuya Y; Kawamoto S; Kamei K; Gonoi T
BMC Genomics; 2016 May; 17():358. PubMed ID: 27185182
[TBL] [Abstract][Full Text] [Related]
5. Proteome Analysis Reveals the Conidial Surface Protein CcpA Essential for Virulence of the Pathogenic Fungus
Voltersen V; Blango MG; Herrmann S; Schmidt F; Heinekamp T; Strassburger M; Krüger T; Bacher P; Lother J; Weiss E; Hünniger K; Liu H; Hortschansky P; Scheffold A; Löffler J; Krappmann S; Nietzsche S; Kurzai O; Einsele H; Kniemeyer O; Filler SG; Reichard U; Brakhage AA
mBio; 2018 Oct; 9(5):. PubMed ID: 30279286
[No Abstract] [Full Text] [Related]
6. Hide, Keep Quiet, and Keep Low: Properties That Make Aspergillus fumigatus a Successful Lung Pathogen.
Escobar N; Ordonez SR; Wösten HA; Haas PJ; de Cock H; Haagsman HP
Front Microbiol; 2016; 7():438. PubMed ID: 27092115
[TBL] [Abstract][Full Text] [Related]
7. Human Bronchial Epithelial Cells Inhibit Aspergillus fumigatus Germination of Extracellular Conidia via FleA Recognition.
Richard N; Marti L; Varrot A; Guillot L; Guitard J; Hennequin C; Imberty A; Corvol H; Chignard M; Balloy V
Sci Rep; 2018 Oct; 8(1):15699. PubMed ID: 30356167
[TBL] [Abstract][Full Text] [Related]
8. Aspergillus fumigatus Strain-Specific Conidia Lung Persistence Causes an Allergic Broncho-Pulmonary Aspergillosis-Like Disease Phenotype.
Jones JT; Liu KW; Wang X; Kowalski CH; Ross BS; Mills KAM; Kerkaert JD; Hohl TM; Lofgren LA; Stajich JE; Obar JJ; Cramer RA
mSphere; 2021 Feb; 6(1):. PubMed ID: 33597172
[No Abstract] [Full Text] [Related]
9. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
10. Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia.
Serbina NV; Cherny M; Shi C; Bleau SA; Collins NH; Young JW; Pamer EG
J Immunol; 2009 Aug; 183(4):2678-87. PubMed ID: 19635902
[TBL] [Abstract][Full Text] [Related]
11. Role of respiration in the germination process of the pathogenic mold Aspergillus fumigatus.
Taubitz A; Bauer B; Heesemann J; Ebel F
Curr Microbiol; 2007 May; 54(5):354-60. PubMed ID: 17486408
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary defense mechanisms against opportunistic fungal pathogens.
Waldorf AR
Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
[TBL] [Abstract][Full Text] [Related]
13. Molecular Insights Into Development and Virulence Determinants of
Shankar J; Tiwari S; Shishodia SK; Gangwar M; Hoda S; Thakur R; Vijayaraghavan P
Front Cell Infect Microbiol; 2018; 8():180. PubMed ID: 29896454
[No Abstract] [Full Text] [Related]
14. Cell Wall Composition Heterogeneity between Single Cells in Aspergillus fumigatus Leads to Heterogeneous Behavior during Antifungal Treatment and Phagocytosis.
Bleichrodt RJ; Foster P; Howell G; Latgé JP; Read ND
mBio; 2020 May; 11(3):. PubMed ID: 32398317
[No Abstract] [Full Text] [Related]
15. Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.
Dos Reis TF; Horta MAC; Colabardini AC; Fernandes CM; Silva LP; Bastos RW; Fonseca MVL; Wang F; Martins C; Rodrigues ML; Silva Pereira C; Del Poeta M; Wong KH; Goldman GH
mBio; 2021 Aug; 12(4):e0145821. PubMed ID: 34372704
[TBL] [Abstract][Full Text] [Related]
16. Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
Hamprecht A; Morio F; Bader O; Le Pape P; Steinmann J; Dannaoui E
Mycopathologia; 2018 Feb; 183(1):151-160. PubMed ID: 28653258
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
Amorim A; Guedes-Vaz L; Araujo R
Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
[TBL] [Abstract][Full Text] [Related]
19. Emergence of azole resistant-
Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
[No Abstract] [Full Text] [Related]
20. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
